title: Toll-like receptors and skin cancer.
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham , Birmingham, AL , USA.
authors.forename: Erin M
authors.initials: EM
authors.lastname: Burns
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham , Birmingham, AL , USA.
authors.forename: Nabiha
authors.initials: N
authors.lastname: Yusuf
keywords: BCC; SCC; Toll-like receptor; innate immunity; melanoma; non-melanoma skin cancer
references.citation: Cancer Res. 2011 Aug 1;71(15):5123-33
references.pmid: 21697281
references.citation: Immunology. 2007 Jan;120(1):103-11
references.pmid: 17034424
references.citation: J Invest Dermatol. 2007 Feb;127(2):331-41
references.pmid: 17068485
references.citation: Cancer Microenviron. 2009 Sep;2 Suppl 1:205-14
references.pmid: 19685283
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: J Am Acad Dermatol. 2002 Sep;47(3):390-8
references.pmid: 12196749
references.citation: Oral Oncol. 2012 Mar;48(3):226-32
references.pmid: 22070917
references.citation: Br J Haematol. 2002 Aug;118(2):638-45
references.pmid: 12139759
references.citation: Immunol Lett. 2003 Jan 22;85(2):85-95
references.pmid: 12527213
references.citation: Eur J Dermatol. 2011 Nov-Dec;21(6):899-905
references.pmid: 21926036
references.citation: Food Chem Toxicol. 2012 Sep;50(9):3019-24
references.pmid: 22743248
references.citation: EMBO J. 2010 Jul 7;29(13):2242-52
references.pmid: 20526283
references.citation: Cancer Genet Cytogenet. 2009 Jul 15;192(2):60-7
references.pmid: 19596255
references.citation: Expert Opin Investig Drugs. 2013 Jan;22(1):149-59
references.pmid: 23205468
references.citation: PLoS Med. 2009 Jan 13;6(1):e10
references.pmid: 19143470
references.citation: J Dermatol Sci. 2002 Dec;30(3):185-94
references.pmid: 12443841
references.citation: Curr Oncol Rep. 2004 Mar;6(2):88-95
references.pmid: 14751085
references.citation: Clin Exp Dermatol. 2003 Nov;28 Suppl 1:24-6
references.pmid: 14616808
references.citation: Cancer Res. 2005 Jun 15;65(12):5009-14
references.pmid: 15958541
references.citation: Mol Biol Rep. 2010 Apr;37(4):1849-55
references.pmid: 19618291
references.citation: J Invest Dermatol. 2009 Jan;129(1):243-6
references.pmid: 18596825
references.citation: Annu Rev Immunol. 2003;21:335-76
references.pmid: 12524386
references.citation: Ann Dermatol. 2010 Nov;22(4):486-9
references.pmid: 21165228
references.citation: Nat Rev Immunol. 2001 Nov;1(2):135-45
references.pmid: 11905821
references.citation: J Immunother. 2005 May-Jun;28(3):220-8
references.pmid: 15838378
references.citation: Br J Dermatol. 2003 Nov;149 Suppl 66:66-70
references.pmid: 14616356
references.citation: Angiogenesis. 2008;11(1):91-9
references.pmid: 18264787
references.citation: Nat Immunol. 2001 Aug;2(8):675-80
references.pmid: 11477402
references.citation: J Invest Dermatol. 2002 Aug;119(2):424-32
references.pmid: 12190866
references.citation: J Invest Dermatol. 2007 Oct;127(10):2391-8
references.pmid: 17508019
references.citation: Apoptosis. 2004 May;9(3):291-8
references.pmid: 15258460
references.citation: Br J Dermatol. 2003 Apr;148(4):670-9
references.pmid: 12752123
references.citation: Clin Exp Dermatol. 2003 Nov;28 Suppl 1:10-2
references.pmid: 14616804
references.citation: J Immunother. 2008 Jun;31(5):520-7
references.pmid: 18463532
references.citation: Arch Dermatol Res. 2013 Jan;305(1):59-67
references.pmid: 23179584
references.citation: Nat Immunol. 2004 Oct;5(10):987-95
references.pmid: 15454922
references.citation: Adv Cancer Res. 2005;93:159-87
references.pmid: 15797447
references.citation: Nat Rev Cancer. 2002 Apr;2(4):301-10
references.pmid: 12001991
references.citation: Br J Dermatol. 2003 Nov;149 Suppl 66:57-8
references.pmid: 14616353
references.citation: Br J Dermatol. 2003 Nov;149 Suppl 66:53-6
references.pmid: 14616352
references.citation: J Cell Mol Med. 2010 Nov;14(11):2592-603
references.pmid: 20629986
references.citation: Mol Cancer Ther. 2008 Nov;7(11):3642-53
references.pmid: 19001446
references.citation: Cancer Biol Ther. 2007 Nov;6(11):1704-9
references.pmid: 17986857
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4565-74
references.pmid: 17671143
references.citation: Clin Diagn Lab Immunol. 2003 Jan;10(1):161-6
references.pmid: 12522054
references.citation: Nat Rev Immunol. 2004 Jul;4(7):499-511
references.pmid: 15229469
references.citation: Nat Immunol. 2002 Feb;3(2):196-200
references.pmid: 11812998
references.citation: J Immunol. 2009 Jul 1;183(1):533-42
references.pmid: 19542464
references.citation: Clin Exp Dermatol. 2003 Nov;28 Suppl 1:33-5
references.pmid: 14616811
references.citation: J Immunol. 2003 Nov 15;171(10):4984-9
references.pmid: 14607893
references.citation: Nature. 2002 Jul 11;418(6894):191-5
references.pmid: 12110890
references.citation: J Cutan Med Surg. 2004 Sep-Oct;8(5):338-52
references.pmid: 15868314
references.citation: Immunol Rev. 2007 Dec;220:60-81
references.pmid: 17979840
references.citation: Trends Immunol. 2004 Jul;25(7):381-6
references.pmid: 15207506
references.citation: Clin Exp Dermatol. 2003 Nov;28 Suppl 1:39-41
references.pmid: 14616813
references.citation: J Leukoc Biol. 2007 Jan;81(1):1-5
references.pmid: 17032697
references.citation: J Am Acad Dermatol. 2013 Jun;68(6):957-66
references.pmid: 23375456
references.citation: Int Immunol. 2003 Jun;15(6):721-30
references.pmid: 12750356
references.citation: Mol Carcinog. 2013 Oct;52(10):760-9
references.pmid: 22431065
references.citation: Infect Immun. 2004 Jan;72(1):352-8
references.pmid: 14688115
references.citation: Arch Dermatol. 2010 Mar;146(3):283-7
references.pmid: 20231499
references.citation: N Engl J Med. 2000 Aug 3;343(5):338-44
references.pmid: 10922424
references.citation: Semin Immunol. 2007 Feb;19(1):24-32
references.pmid: 17275323
references.citation: Nat Rev Immunol. 2004 Mar;4(3):211-22
references.pmid: 15039758
references.citation: Adv Dermatol. 2008;24:33-57
references.pmid: 19256304